Sikhulile Moyo | |
---|---|
Born | |
Alma mater | University of Zimbabwe University of Botswana Sefako Makgatho Health Sciences University Stellenbosch University |
Known for | Moyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant |
Children | 3 |
Scientific career | |
Fields | Immunology, infectious diseases |
Institutions | Botswana–Harvard AIDS Institute Partnership Harvard T.H. Chan School of Public Health |
Thesis | HIV-1C Dynamics and Evolutionary Trends in Botswana |
Doctoral advisor | Susan Engelbrecht Tulio de Oliveira |
Sikhulile M. Moyo is a Zimbabwean virologist working as the laboratory director of the Botswana–Harvard AIDS Institute Partnership in Gaborone.[1][2] He is a research associate in immunology and infectious diseases at the Harvard T.H. Chan School of Public Health. In November 2021, Moyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant. In 2022, Moyo was listed in the Time 100 list.